GRAIL is a pioneering biotechnology company focused on transforming cancer detection through innovative diagnostic solutions. The company is dedicated to advancing the field of early cancer detection with its Galleri Multi-Cancer Early Detection (MCED) test, which aims to identify multiple types of cancer at their earliest stages. GRAIL emphasizes collaboration with healthcare providers, decision-makers, and key opinion leaders to ensure the effective implementation and utilization of its groundbreaking technologies. With a commitment to scientific excellence and compliance, GRAIL fosters a culture of education and support within the healthcare community, while also offering a comprehensive benefits package to its employees.